Discover 926 paid clinical trials in Hillsboro, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 926
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Location: Portland OR, Vancouver WA, Seattle WA, Duarte CA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07227415
Phase 1, Phase 2, Recruiting
New
Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck Cancers
for
Head and Neck Carcinoma, Hypopharyngeal Carcinoma,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18 - 70+
Code: NCT07857655
Recruiting
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
for
Prostate Carcinoma
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT06011499
Recruiting
Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML
for
Acute Monocytic Leukemia, Acute Myeloid Leukemia
Location: Portland OR, Miami FL
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT06504459
Phase 2, Recruiting
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
for
Atrial Fibrillation, Esophageal Carcinoma
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT06067438
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Targeted Pathway Inhibition in Patients With Pancreatic Cancer
Location: Portland OR, Stanford CA, Gilbert AZ, Westwood KS,
Sponsor: Miltenyi Biomedicine GmbH
Sex: All
Age: 18+
Code: NCT06116110
Recruiting
IVIG for Infection Prevention After CAR-T-Cell Therapy
for
Hematologic Malignancies
Location: Portland OR, Seattle WA, Duarte CA, New York NY,
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 18+
Code: NCT05952804
Phase 2, Recruiting
Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma
for
Diffuse Large B-Cell Lymphoma, High Grade B-Cell Lymphoma
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18 - 70+
Code: NCT06249191
Phase 1, Phase 2, Recruiting
Feasibility of FMISO in Brain Tumors
for
IDH Wild Type Glioblastoma
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT03649880
Phase 2, Recruiting
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
for
Peripheral T-Cell Lymphoma, Not Otherwise Specified,
Location: Portland OR, Seattle WA, Vancouver, San Francisco CA,
Sponsor: Corvus Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06561048
Phase 3, Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
for
Urinary Bladder Neoplasms,
Location: Portland OR, Seattle WA, Bakersfield CA, Los Angeles CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06833073
Phase 2, Recruiting
Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia
for
Acute Myeloid Leukemia,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT06357182
Phase 1, Recruiting
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
for
Advanced Malignant Solid Neoplasm,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT05705492
Phase 2, Recruiting
Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy